Transduction for AAV with Sean Hart

Published on: 

Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured.

Chris Spivey, editorial director, speaks with Sean Hart, CEO and SCO of LumaCyte, on percent transduction for AAV measured. The full discussion can and more can be viewed here.

Related Content:

VaccinesDosage Forms
WHO Activates Global Health Emergency Corp in Response to Mpox
Regulatory Collaboration on Mpox Treatments Summarized in Report
FDA Approves RSV Vaccine